xolair (drug)

literal strings: xolair, XOLAIR, Xolair

Help NELL Learn!

NELL wants to know if these beliefs are correct.
If they are or ever were, click thumbs-up. Otherwise, click thumbs-down.

• xolair is a drug     
• xolair is a drug having the side effect side_effects (disease)     
• xolair is a drug that might treat asthma (disease)     
• xolair is a drug worked on by novartis (biotechcompany)     

categories

• drug(100.0%)
• MBL @524 (93.8%) on 05-mar-2012 [ Promotion of drug:xolair drugpossiblytreatsphysiologicalcondition disease:asthma ]
• LE @1098 (63.1%) on 21-jan-2018
• CPL @1111 (66.9%) on 25-jun-2018 [ "period patient was treated with _" "patient was treated with _" "postapproval use of _" "post-approval use of _" "_ is an injectable medicine" "same period patient was treated with _" "new medicine called _" ] using xolair
• OE @830 (96.2%) on 13-apr-2014 [   ] using xolair
• SEAL @178 (100.0%) on 14-dec-2010 [ 1 2 3 4 5 6 7 8 9 10 11 ] using xolair
• product(100.0%)
• LE @1098 (76.6%) on 21-jan-2018
• OE @841 (88.1%) on 25-may-2014 [ http://www.xolairpregnancyregistry.com/ http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://www.genentech-access.com/xolair/hcp http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://www.gene.com/patients/medicines/xolair http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://www.medilexicon.com/drugs/xolair.php http://www.genentech-access.com/xolair/hcp http://www.xolair.com/ http://www.xolair.com/ http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://www.xolair.com/ http://www.xolair.com/ http://en.wikipedia.org/wiki/Omalizumab http://www.gene.com/patients/medicines/xolair http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://asthma.about.com/od/treatmentoptions/a/art_xolair.htm http://asthma.about.com/od/treatmentoptions/a/art_xolair.htm http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7f6a2191-adfb-48b9-9bfa-0d9920479f0d  ] using xolair
• SEAL @111 (99.2%) on 02-jun-2010 [ 1 2 3 4 5 6 7 ] using xolair
• CPL @1099 (89.0%) on 22-jan-2018 [ "new medication called _" "_ is a prescription medicine" "healthcare provider recommends taking _" "_ is a controller medication" "_ is a prescription medication" "_ is currently the only drug" "drugs , such as _" "similar drug called _" "new drug called _" "_ is not a fast-acting asthma medication" "shared decision about _" "_ is a targeted therapy" "_ is the first drug" "drug similar to _" "medications such as _" "_ has no abuse potential" "drugs like _" "other drugs affect _" "new drugs like _" "medications similar to _" "Generic name of _" "medications like _" "_ is considered a pregnancy Category B medication" "_ is an immunomodulator" "Ask patient community about _" "_ is the first medication" "patient community about _" "other medications such as _" "you are getting genuine _" "adverse event reports related to _" "medication called _" "Community Ask patient community about _" "specific drug interactions with _" "provider recommends taking _" "drug interactions between _" ] using xolair

relations

• drughassideeffect
• side_effects (disease) (93.8%)
• SEAL @521 (93.8%) on 28-feb-2012 [ 1 2 3 4 ] using (xolair, side_effects)
• drugpossiblytreatsphysiologicalcondition
• asthma (disease) (93.8%)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 medications such as arg1" "arg2 patients taking arg1" "arg2 medicine called arg1" "arg2 patients who took arg1" ] using (xolair, asthma)
• drugworkedonbyagent
• novartis (biotechcompany) (100.0%)
• OE @1091 (100.0%) on 27-dec-2017 [ https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment- https://www.gene.com/media/press-releases/14551/2013-10-10/fda-files-genentechs-supplemental-biolog https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment-  ] using (xolair, novartis)
• SEAL @269 (87.5%) on 24-may-2011 [ 1 2 3 ] using (xolair, novartis)

NELL has only weak evidence for items listed in grey

• drughassideeffect
• anaphylaxis
• CPL @1098 (50.0%) on 21-jan-2018 [ "arg1 side effects such as arg2" ] using (xolair, anaphylaxis)
• drugworkedonbyagent
• genentech (biotechcompany)
• SEAL @524 (50.0%) on 04-mar-2012 [ 1 ] using (xolair, genentech)
• novartis_pharmaceutical
• SEAL @269 (75.0%) on 24-may-2011 [ 1 2 ] using (xolair, novartis_pharmaceuticals)
• drughassideeffect
• adverse_events
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, adverse_events)
• side_effects (bacteria)
• SEAL @521 (93.8%) on 28-feb-2012 [ 1 2 3 4 ] using (xolair, side_effects)
• events (bakedgood)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (beverage)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (building)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (celltype)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (chemical)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (cognitiveactions)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (condiment)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (date)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (eventoutcome)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (female)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (geometricshape)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (hobby)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (medicalprocedure)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (mlarea)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (musicalbum)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (park)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (politicsissue)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (profession)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (stateorprovince)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (televisionshow)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (tradeunion)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (visualartist)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• events (visualizablescene)
• CPL @1095 (75.0%) on 17-jan-2018 [ "arg2 in patients using arg1" "arg2 reported with arg1" ] using (xolair, events)
• drugpossiblytreatsphysiologicalcondition
• asthma (academicfield)
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 medications such as arg1" "arg2 patients taking arg1" "arg2 medicine called arg1" "arg2 patients who took arg1" ] using (xolair, asthma)
• risk
• CPL @1105 (50.0%) on 25-mar-2018 [ "arg1 is a medication for arg2" ] using (xolair, risk)
• use (city)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 is only indicated for arg2" ] using (xolair, use)
• use (visualizablething)
• CPL @1104 (50.0%) on 18-mar-2018 [ "arg1 is only indicated for arg2" ] using (xolair, use)
• drugworkedonbyagent
• novartis (bank)
• OE @1091 (100.0%) on 27-dec-2017 [ https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment- https://www.gene.com/media/press-releases/14551/2013-10-10/fda-files-genentechs-supplemental-biolog https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment-  ] using (xolair, novartis)
• SEAL @269 (87.5%) on 24-may-2011 [ 1 2 3 ] using (xolair, novartis)
• novartis_pharmaceuticals (bank)
• SEAL @269 (75.0%) on 24-may-2011 [ 1 2 ] using (xolair, novartis_pharmaceuticals)
• novartis (drug)
• OE @1091 (100.0%) on 27-dec-2017 [ https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment- https://www.gene.com/media/press-releases/14551/2013-10-10/fda-files-genentechs-supplemental-biolog https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment-  ] using (xolair, novartis)
• SEAL @269 (87.5%) on 24-may-2011 [ 1 2 3 ] using (xolair, novartis)
• novartis_pharmaceuticals (governmentorganization)
• SEAL @269 (75.0%) on 24-may-2011 [ 1 2 ] using (xolair, novartis_pharmaceuticals)
• genentech (magazine)
• SEAL @524 (50.0%) on 04-mar-2012 [ 1 ] using (xolair, genentech)
• novartis (university)
• OE @1091 (100.0%) on 27-dec-2017 [ https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment- https://www.gene.com/media/press-releases/14551/2013-10-10/fda-files-genentechs-supplemental-biolog https://www.gene.com/media/press-releases/5707/2002-12-18/genentech-and-novartis-submit-amendment-  ] using (xolair, novartis)
• SEAL @269 (87.5%) on 24-may-2011 [ 1 2 3 ] using (xolair, novartis)